Anbioton has been acquired by Elfa Medicamentos

The shareholders of Anbioton have sold the company to Elfa Medicamentos, a Patria Investimentos portfolio company.

Anbioton is focused on the Brazilian pharmaceutical distribution market. The company serves close to 1,400 private hospitals and 200 public entities through partnership agreements with more than 75 pharmaceutical companies.

Elfa Medicamentos was founded in 1989 by Edalmo Leite Fernandes Assis. The company’s operations are focused on the distribution of specialty medicines and generic and branded drugs, hospital supplies, and high value-added solutions for medical plans, clinics, hospitals, government, doctors and patients across the country.

One of Oaklins’ teams in Brazil acted as the exclusive sell-side advisor for Anbioton and its shareholders.

Service

M&A sell-side

Parties

Talk to the deal team

Irajá Guimarães

Partner

São Paulo, Brazil
Oaklins Olimpia Partners

View profile Get in touch

Victor Andreoli

Partner

São Paulo, Brazil
Oaklins Olimpia Partners

View profile Get in touch

Thomas Monteiro

Partner

São Paulo, Brazil
Oaklins Olimpia Partners

View profile Get in touch

Related deals

Den Berk Délice accelerates growth through strategic partnership

Private Equity | Agriculture

Den Berk Délice accelerates growth through strategic partnership

Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.

Learn more

Bayer AG has entered into a takeover agreement with Cara Care

Healthcare | TMT

Bayer AG has entered into a takeover agreement with Cara Care

Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

Learn more

Mark Climate Technology has acquired Heber GmbH

Private Equity | Industrial Machinery & Components | Other Industries

Mark Climate Technology has acquired Heber GmbH

Heber GmbH has been acquired by Mark Climate Technology, a specialist in climate control systems and a portfolio company of Bolster Investment Partners. This partnership strengthens the positions of both companies in the global market for innovative and sustainable climate solutions, as well as creating unique synergies. Mark Climate's expertise in standardized, scalable solutions is enhanced by Heber's emphasis on customer-specific customization.

Learn more